Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
CALL
West Pharmaceutical
WST
$24.6B
| $19.8M | ﹤0.01% |
88,400
+46,200
| +109% | +$12.7M |
|
2027
CALL
Ralph Lauren
RL
$23.2B
| $19.8M | ﹤0.01% |
89,500
+43,900
| +96% | +$10.9M |
|
2028
CALL
Enovix
ENVX
$963M
| $19.7M | ﹤0.01% |
3,071,543
+734,400
| +31% | +$6.54M |
|
2029
PUT
Sanofi
SNY
$105B
| $19.7M | ﹤0.01% |
355,600
-49,500
| -12% | -$2.68M |
|
2030
Whirlpool
WHR
$2.7B
| $19.7M | ﹤0.01% |
218,794
-69,665
| -24% | -$7.39M |
|
2031
PUT
Baker Hughes
BKR
$64.3B
| $19.7M | ﹤0.01% |
448,600
-207,400
| -32% | -$9.25M |
|
2032
PUT
Texas Roadhouse
TXRH
$13.6B
| $19.7M | ﹤0.01% |
118,100
+32,700
| +38% | +$5.79M |
|
|
DAY
2033
DELISTED
Dayforce
DAY
| $19.6M | ﹤0.01% |
336,394
+285,369
| +559% | +$18.4M |
|
2034
Intellia Therapeutics
NTLA
$1.67B
| $19.6M | ﹤0.01% |
2,757,568
+263,498
| +11% | +$2.66M |
|
2035
CALL
Transmedics
TMDX
$3.07B
| $19.6M | ﹤0.01% |
291,200
+54,700
| +23% | +$3.76M |
|
2036
The GEO Group
GEO
$4.11B
| $19.6M | ﹤0.01% |
670,696
-600,781
| -47% | -$17.2M |
|
2037
FTI Consulting
FCN
$4.19B
| $19.6M | ﹤0.01% |
119,384
+75,998
| +175% | +$13.7M |
|
2038
PUT
Carpenter Technology
CRS
$27B
| $19.6M | ﹤0.01% |
108,100
-15,200
| -12% | -$2.93M |
|
2039
PUT
State Street SPDR S&P Bank ETF
KBE
$1.76B
| $19.6M | ﹤0.01% |
369,600
-2,050,500
| -85% | -$115M |
|
2040
PUT
D-Wave Quantum Inc
QBTS
$7.88B
| $19.5M | ﹤0.01% |
2,571,700
+837,100
| +48% | +$5.62M |
|
2041
Array Technologies
ARRY
$778M
| $19.5M | ﹤0.01% |
4,003,278
+3,945,869
| +6,873% | +$25.4M |
|
2042
Coupang
CPNG
$29B
| $19.5M | ﹤0.01% |
888,943
-2,680,221
| -75% | -$62.3M |
|
2043
CALL
FMC
FMC
$1.27B
| $19.5M | ﹤0.01% |
462,000
+75,000
| +19% | +$3.33M |
|
2044
CALL
Erie Indemnity
ERIE
$13.4B
| $19.5M | ﹤0.01% |
46,500
-8,900
| -16% | -$3.63M |
|
2045
PUT
Martin Marietta Materials
MLM
$32.9B
| $19.5M | ﹤0.01% |
40,700
+24,400
| +150% | +$12.4M |
|
2046
SiriusXM
SIRI
$9.59B
| $19.5M | ﹤0.01% |
863,151
+626,371
| +265% | +$14.8M |
|
2047
Hims & Hers Health
HIMS
$6.57B
| $19.5M | ﹤0.01% |
658,410
+510,455
| +345% | +$19M |
|
2048
PUT
Quanta Services
PWR
$103B
| $19.4M | ﹤0.01% |
76,400
-3,000
| -4% | -$867K |
|
2049
PUT
Truist Financial
TFC
$64.9B
| $19.4M | ﹤0.01% |
471,700
+135,600
| +40% | +$6.04M |
|
2050
Oscar Health
OSCR
$10.1B
| $19.4M | ﹤0.01% |
1,480,225
+1,051,614
| +245% | +$15.6M |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.